ArticleBMC cancer2024

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Xinpei Ci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.